FDA Alerts Public to Urgent Recall of Contaminated Systane Eye Drops

The Food and Drug Administration (FDA) has announced a nationwide recall of a certain batch of Systane Lubricant Eye Drops Ultra PF after reports of potential fungal contamination. This recall, issued on December 23, targets single-use vials included in 25-count packages, following a consumer complaint.

Information on the Eye Drop Recall

The product involved, produced by Alcon Laboratories, is identified by lot number 10101, UPC 300651432060, and an expiration date of September 2025. These eye drops, distributed nationwide through major retailers like Target, Walmart, Walgreens, and various online vendors, are commonly used to relieve symptoms related to dry eyes, including irritation and burning.

After a consumer alerted the FDA and Alcon Laboratories to the presence of "foreign material" in the vials, investigations confirmed the contaminant was fungal in origin.

Add Cosmo Herald as a Preferred Source

Health Implications of Contamination

Fungal contamination in ophthalmic products can lead to severe health complications, potentially resulting in infections that threaten vision. Though such cases are uncommon, they may become life-threatening for those with weakened immune systems.

Typical symptoms associated with fungal eye infections may include:

Pain or discomfort in the eye
Redness
Vision becoming cloudy or blurry
Increased sensitivity to light
Excessive tearing
Discharge from the eye

People with conditions such as diabetes, compromised immunity, or those on corticosteroid treatments are particularly vulnerable to serious consequences.

Recommended Measures and Current Status

There have been no reported infections or other adverse health effects associated with this product lot to date. Nevertheless, the FDA urges consumers to:

Cease use of the recalled eye drops immediately.
Return any affected products to the point of purchase for a refund or exchange.
Seek medical attention if experiencing symptoms that could indicate a fungal eye infection.

Adverse reactions can be reported to the FDA’s MedWatch Adverse Event Reporting Program via its official online portal, as well as through mail or fax.

Context of Recent FDA Safety Recalls

This recall involving Systane Lubricant Eye Drops Ultra PF follows several recent FDA recall announcements. These include dietary supplements found to contain undeclared substances and certain blood pressure medications contaminated with hazardous impurities.

Consumers are advised to remain vigilant about product recalls by regularly consulting the FDA’s announcements and promptly reporting any adverse effects via the MedWatch Adverse Event Reporting Program.